Showing results (501-510 of 606) with videos related to

Sort By:
Pageof 61
Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical trial of folinic acid to reduce vincristine neurotoxicityD V Jackson, R A McMahan, E K Pope, et al.
Journal of Applied Microbiology|August 18, 2012
Test method development to evaluate hot, humid air decontamination of materials contaminated with Bacillus anthracis ∆Sterne and B. thuringiensis Al Hakam sporesT L Buhr, A A Young, Z A Minter, et al.
Pediatrics|January 31, 1998
Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter studyM T Britto, J M Garrett, M A Dugliss, et al.
Family Medicine|May 1, 1992
Teaching family-centered perinatal care in family medicine, Part IJ E Scherger, C Levitt, L S Acheson, et al.
Family Medicine|July 1, 1992
Teaching family-centered perinatal care in family medicine, Part 2J E Scherger, C Levitt, L S Acheson, et al.
Cancer|December 1, 1982
Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology AssociationH B Muss, F Richards, D V Jackson, et al.
Cancer|June 15, 1981
Combination chemotherapy with and without the methanol-extracted residue of bacillus Calmette-Guerin (MER) in extensive non-small-cell lung cancer: a prospective randomized study for the Piedmont Oncology AssociationF Richards, V Howard, A Shore, et al.
The European Respiratory Journal|June 1, 1995
Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatmentP I Shah, A Bush, G J Canny, et al.
Prostaglandins & Other Lipid Mediators|February 17, 1999
Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseasesJ B Travers, R C Murphy, C A Johnson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 26, 1998
Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesisY Pei, L A Barber, R C Murphy, et al.
Pageof 61